相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Targeting ApoC-III to Reduce Coronary Disease Risk
Sumeet A. Khetarpal et al.
CURRENT ATHEROSCLEROSIS REPORTS (2016)
FoxO1 Plays an Important Role in Regulating β-Cell Compensation for Insulin Resistance in Male Mice
Ting Zhang et al.
ENDOCRINOLOGY (2016)
Effect of Hypertriglyceridemia on Beta Cell Mass and Function in ApoC3 Transgenic Mice
Yun-Zi Liu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2016)
ApoC-III inhibits clearance of triglyceride-rich lipoproteins through LDL family receptors
Philip L. S. M. Gordts et al.
JOURNAL OF CLINICAL INVESTIGATION (2016)
Apolipoprotein C-III: From Pathophysiology to Pharmacology
Giuseppe Danilo Norata et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2015)
Apolipoprotein C3 Gene Polymorphisms Are Not a Risk Factor for Developing Non-Alcoholic Fatty Liver Disease: A Meta-Analysis
Haiying Zhang et al.
HEPATITIS MONTHLY (2014)
Loss-of-Function Mutations in APOC3 and Risk of Ischemic Vascular Disease
Anders Berg Jorgensen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Targeting APOC3 in the Familial Chylomicronemia Syndrome
Daniel Gaudet et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Loss-of-Function Mutations in APOC3, Triglycerides, and Coronary Disease
Jacy Crosby et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Lack of association between apolipoprotein C3 gene polymorphisms and risk of nonalcoholic fatty liver disease in a Chinese Han population vs
Tong-Hong Niu et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2014)
Antisense Oligonucleotide Inhibition of Apolipoprotein C-III Reduces Plasma Triglycerides in Rodents, Nonhuman Primates, and Humans
Mark J. Graham et al.
CIRCULATION RESEARCH (2013)
Abdominal fat interacts with PNPLA3 I148M, but not with the APOC3 variant in the pathogenesis of liver steatosis in chronic hepatitis C
R. Zampino et al.
JOURNAL OF VIRAL HEPATITIS (2013)
A Gene Variant of PNPLA3, But Not of APOC3, Is Associated With Histological Parameters of NAFLD in an Obese Population
A. Verrijken et al.
OBESITY (2013)
Dual Metabolic Defects Are Required to Produce Hypertriglyceridemia in Obese Subjects
Marja-Riitta Taskinen et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2011)
Dissociation Between APOC3 Variants, Hepatic Triglyceride Content and Insulin Resistance
Julia Kozlitina et al.
HEPATOLOGY (2011)
Apolipoprotein CIII Overexpressing Mice Are Predisposed to Diet-Induced Hepatic Steatosis and Hepatic Insulin Resistance
Hui-Young Lee et al.
HEPATOLOGY (2011)
Missense Mutation in APOC3 within the C-terminal Lipid Binding Domain of Human ApoC-III Results in Impaired Assembly and Secretion of Triacylglycerol-rich Very Low Density Lipoproteins EVIDENCE THAT ApoC-III PLAYS A MAJOR ROLE IN THE FORMATION OF LIPID PRECURSORS WITHIN THE MICROSOMAL LUMEN
Wen Qin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
The APOC3 T-455C and C-482T promoter region polymorphisms are not associated with the severity of liver damage independently of PNPLA3 I148M genotype in patients with nonalcoholic fatty liver
Luca Valenti et al.
JOURNAL OF HEPATOLOGY (2011)
Lack of effect of apolipoprotein C3 polymorphisms on indices of liver steatosis, lipid profile and insulin resistance in obese Southern Europeans
Federica Sentinelli et al.
LIPIDS IN HEALTH AND DISEASE (2011)
Fructose induced lipogenesis: from sugar to fat to insulin resistance
Varman T. Samuel
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2011)
Macrophages, Inflammation, and Insulin Resistance
Jerrold M. Olefsky et al.
ANNUAL REVIEW OF PHYSIOLOGY (2010)
Functional analysis of the missense APOC3 mutation Ala23Thr associated with human hypotriglyceridemia
Meenakshi Sundaram et al.
JOURNAL OF LIPID RESEARCH (2010)
Pathology of nonalcoholic fatty liver disease
Elizabeth M. Brunt
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2010)
The role of fructose in the pathogenesis of NAFLD and the metabolic syndrome
Jung Sub Lim et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2010)
Apolipoprotein C3 Gene Variants in Nonalcoholic Fatty Liver Disease
Kitt Falk Petersen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis.
Arun J. Sanyal et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Fructose overconsumption causes dyslipidemia and ectopic lipid deposition in healthy subjects with and without a family history of type 2 diabetes
Kim-Anne Le et al.
AMERICAN JOURNAL OF CLINICAL NUTRITION (2009)
Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis: Selected Practical Issues in Their Evaluation and Management
Raj Vuppalanchi et al.
HEPATOLOGY (2009)
Liver-specific Deletion of the Growth Hormone Receptor Reveals Essential Role of Growth Hormone Signaling in Hepatic Lipid Metabolism
Yong Fan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Consuming fructose-sweetened, not glucose-sweetened, beverages increases visceral adiposity and lipids and decreases insulin sensitivity in overweight/obese humans
Kimber L. Stanhope et al.
JOURNAL OF CLINICAL INVESTIGATION (2009)
Kupffer cells in non-alcoholic fatty liver disease: The emerging view
Gyoergy Baffy
JOURNAL OF HEPATOLOGY (2009)
The ever-expanding role of degradation in the regulation of apolipoprotein B metabolism
Henry N. Ginsberg et al.
JOURNAL OF LIPID RESEARCH (2009)
Pediatric non-alcoholic fatty liver disease: Preventive and therapeutic value of lifestyle intervention
Valerio Nobili et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2009)
Diagnosis and therapy of nonalcoholic steatohepatitis
Dawn M. Torres et al.
GASTROENTEROLOGY (2008)
Pediatric nonalcoholic fatty liver disease
Stacee M. Lerret et al.
GASTROENTEROLOGY NURSING (2008)
FoxO1 mediates insulin-dependent regulation of hepatic VLDL production in mice
Adama Kamagate et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
Proteomic analysis of fructose-induced fatty liver in hamsters
Lihe Zhang et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2008)
A Null Mutation in Human APOC3 Confers a Favorable Plasma Lipid Profile and Apparent Cardioprotection
Toni I. Pollin et al.
SCIENCE (2008)
Evaluation and management of obesity-related nonalcoholic fatty liver disease
Clare Nugent et al.
NATURE CLINICAL PRACTICE GASTROENTEROLOGY & HEPATOLOGY (2007)
Effects of apoA-V on HDL and VLDL metabolism in APOC3 transgenic mice
Shen Qu et al.
JOURNAL OF LIPID RESEARCH (2007)
PPARα mediates the hypolipidemic action of fibrates by antagonizing FoxO1
Shen Qu et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2007)
Alanine aminotransferase levels and fatty liver in childhood obesity: Associations with insulin resistance, adiponectin, and visceral fat
Tania S. Burgert et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
Apolipoproteins C-III and A-V as predictors of very-low-density lipoprotein triglyceride and apolipoprotein B-100 kinetics
DC Chan et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2006)
ApoC-III deficiency prevents hyperlipidemia induced by apoE overexpression
G Gerritsen et al.
JOURNAL OF LIPID RESEARCH (2005)
Apolipoprotein C3 deficiency results in diet-induced obesity and aggravated insulin resistance in mice
I Duivenvoorden et al.
DIABETES (2005)
Rate of production of plasma and very-low-density lipoprotein (VLDL) apolipoprotein C-III is strongly related to the concentration and level of production of VLDL triglyceride in male subjects with different body weights and levels of insulin sensitivity
JS Cohn et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2004)
Foxo1 mediates insulin action on apoC-III and triglyceride metabolism
J Altomonte et al.
JOURNAL OF CLINICAL INVESTIGATION (2004)
Disruption of insulin receptor substrate 2 causes type 2 diabetes because of liver insulin resistance and lack of compensatory β-cell hyperplasia
N Kubota et al.
DIABETES (2000)
分享论文
